Picture
SEARCH
What are you looking for?
Need help finding what you are looking for? Contact Us
Compare

PUBLISHER: Blueweave Consulting | PRODUCT CODE: 1566023

Cover Image

PUBLISHER: Blueweave Consulting | PRODUCT CODE: 1566023

India In-Vitro Diagnostics Market, By Product and Services; By Technique; By Application; By End User; By Region, Trend Analysis, Competitive Landscape & Forecast, 2019-2030

PUBLISHED:
PAGES: 130 Pages
DELIVERY TIME: 2-3 business days
SELECT AN OPTION
Unprintable PDF (Single User License)
USD 2740
Unprintable PDF (Group License)
USD 3000
PDF (Enterprise License)
USD 3500

Add to Cart

India In-Vitro Diagnostics (IVD) Market Size to Surpass USD 2.56 Billion by 2030

India In-Vitro Diagnostics (IVD) Market is flourishing due to the increasing prevalence of non-communicable diseases, the adoption of advanced diagnostic tools, and growing investments in healthcare infrastructure

BlueWeave Consulting, a leading strategic consulting and market research firm, in its recent study, estimated India In-Vitro Diagnostics (IVD) Market size by value at USD 1.69 billion in 2023. During the forecast period between 2024 and 2030, BlueWeave expects India In-Vitro Diagnostics (IVD) Market size to expand at a CAGR of 6.25% reaching a value of USD 2.56 billion by 2030. The In-Vitro Diagnostics (IVD) Market in India is propelled by the rising prevalence of infectious diseases, chronic conditions, and the aging population. Government initiatives like "Make in India" and regulatory support are fostering domestic production and attracting global players. Technological advancements in immunodiagnostics, molecular diagnostics, and clinical chemistry are enabling earlier disease detection and personalized treatments. Notable market developments include strategic partnerships and the accelerated growth driven by the COVID-19 pandemic. These factors collectively position the Indian IVD market for continued expansion and the adoption of innovative diagnostic solutions.

Opportunities - Growing Demand for Rapid and Accessible Diagnostic Solutions

The growing demand for rapid and accessible diagnostic solutions has become a significant trend within the in-vitro diagnostics (IVD) industry, notably accelerated by the COVID-19 pandemic. Emphasis on early detection and preventive healthcare is driving advancements in technologies such as liquid biopsy, digital pathology, and microfluidics, which are reshaping the diagnostic landscape. This surge in demand is fueled by the need for faster and more accurate testing methods, contributing to notable growth in the Indian IVD market. The rise of point-of-care testing and overall expansion of diagnostic capabilities reflect this increasing need. As healthcare systems worldwide aim to deliver timely and efficient diagnostic solutions, the industry is evolving to meet these demands through innovative technologies and enhanced accessibility.

North India is at the Forefront of India In-Vitro Diagnostics (IVD) Market

With a dense population and a sophisticated healthcare network, North India stands as a prime market for IVD products. States like Uttar Pradesh, Bihar, and Haryana, along with the National Capital Region (Delhi, Gurugram, Noida), offer a vast patient base and a robust infrastructure of hospitals, clinics, and diagnostic labs. This combination, coupled with growing economic prosperity and increased healthcare spending, solidifies North India's leading position in the IVD industry.

Impact of Escalating Geopolitical Tensions on India In-Vitro Diagnostics (IVD) Market

India In-Vitro Diagnostics (IVD) Market may face significant challenges from intensifying geopolitical tensions across the world. These tensions often disrupt supply chains, leading to shortages of critical raw materials and components. Trade restrictions and sanctions further exacerbate these issues, increasing costs and delaying the import of advanced technologies. The resulting uncertainty can deter foreign investments and collaborations, limiting opportunities for innovation and growth. As geopolitical conflicts continue to evolve, the Indian IVD market faces the ongoing challenge of ensuring a consistent supply, controlling costs, and maintaining overall stability.

Competitive Landscape

India In-Vitro Diagnostics (IVD) Market is fragmented, with numerous players serving the market. The key players dominating India In-Vitro Diagnostics (IVD) Market include Roche Diagnostics, Abbott Laboratories, Beckman Coulter, Becton and Dickinson, Sysmex, Transasia Bio-Medicals Ltd, Thermo Fisher Scientific Inc, J Mitra & Co Pvt Ltd, Advatech Healthcare Pvt Ltd, Tulip Diagnostics Pvt Ltd, Siemens Healthcare Pvt Ltd, and Bio-Rad Laboratories India Pvt Ltd. The key marketing strategies adopted by the players are facility expansion, product diversification, alliances, collaborations, partnerships, and acquisitions to expand their customer reach and gain a competitive edge in the overall market.

The report's in-depth analysis provides information about growth potential, upcoming trends, and India In-Vitro Diagnostics (IVD) Market statistics. It also highlights the factors driving forecasts of total market size. The report promises to provide recent technology trends in India In-Vitro Diagnostics (IVD) Market along with industry insights to help decision-makers make sound strategic decisions. Furthermore, the report also analyses the growth drivers, challenges, and competitive dynamics of the market.

Product Code: BWC24657

Table of Contents

1. Research Framework

  • 1.1. Research Objective
  • 1.2. Product Overview
  • 1.3. Market Segmentation

2. Executive Summary

3. India In-Vitro Diagnostics (IVD) Market Insights

  • 3.1. Industry Value Chain Analysis
  • 3.2. DROC Analysis
    • 3.2.1. Growth Drivers
      • 3.2.1.1. Increasing prevalence of chronic diseases
      • 3.2.1.2. Innovations in IVD technology, such as point-of-care testing, molecular diagnostics, and automation
      • 3.2.1.3. Rising healthcare expenditure
      • 3.2.1.4. Growing awareness about early disease detection
    • 3.2.2. Restraints
      • 3.2.2.1. Unfavorable reimbursement scenario
      • 3.2.2.2. High cost of development
      • 3.2.2.3. Stringent regulatory environment
    • 3.2.3. Opportunities
      • 3.2.3.1. Emerging technologies such as liquid biopsy, digital pathology, and microfluidics
      • 3.2.3.2. Increasing adoption of personalized medicine
      • 3.2.3.3. Growing demand for rapid and accessible diagnostic solutions
    • 3.2.4. Challenges
      • 3.2.4.1. Shortage of skilled professionals in the IVD industry
      • 3.2.4.2. Increasing concerns about data privacy and security
  • 3.3. Technological Advancements/Recent Developments
  • 3.4. Regulatory Framework
  • 3.5. Porter's Five Forces Analysis
    • 3.5.1. Bargaining Power of Suppliers
    • 3.5.2. Bargaining Power of Buyers
    • 3.5.3. Threat of New Entrants
    • 3.5.4. Threat of Substitutes
    • 3.5.5. Intensity of Rivalry

4. India In-Vitro Diagnostics (IVD) Market: Marketing Strategies

5. India In-Vitro Diagnostics (IVD) Market Overview

  • 5.1. Market Size & Forecast, 2019-2030
    • 5.1.1. By Value (USD Billion)
  • 5.2. Market Share & Forecast
    • 5.2.1. By Product and Services
      • 5.2.1.1. Reagents and Kits
      • 5.2.1.2. Instruments
      • 5.2.1.3. Software and Services
    • 5.2.2. By Technique
      • 5.2.2.1. Molecular Diagnostics
      • 5.2.2.2. Tissue Diagnostics
      • 5.2.2.3. Clinical Chemistry
      • 5.2.2.4. Immunodiagnostics
      • 5.2.2.5. Hematology
    • 5.2.3. By Application
      • 5.2.3.1. Infectious Diseases
      • 5.2.3.2. Cancer
      • 5.2.3.3. Cardiac Diseases
      • 5.2.3.4. Immune System Disorders
      • 5.2.3.5. Nephrological Diseases
      • 5.2.3.6. Gastrointestinal Diseases
      • 5.2.3.7. Others
    • 5.2.4. By End User
      • 5.2.4.1. Standalone Laboratories
      • 5.2.4.2. Hospitals
      • 5.2.4.3. Academic and Medical Schools
      • 5.2.4.4. Point of Care
      • 5.2.4.5. Others
    • 5.2.5. By Region
      • 5.2.5.1. North India
      • 5.2.5.2. South India
      • 5.2.5.3. East India
      • 5.2.5.4. West India

6. North India In-Vitro Diagnostics (IVD) Market

  • 6.1. Market Size & Forecast, 2019-2030
    • 6.1.1. By Value (USD Billion)
  • 6.2. Market Share & Forecast
    • 6.2.1. By Product and Services
    • 6.2.2. By Technique
    • 6.2.3. By Application
    • 6.2.4. By End User

7. South India In-Vitro Diagnostics (IVD) Market

  • 7.1. Market Size & Forecast, 2019-2030
    • 7.1.1. By Value (USD Billion)
  • 7.2. Market Share & Forecast
    • 7.2.1. By Product and Services
    • 7.2.2. By Technique
    • 7.2.3. By Application
    • 7.2.4. By End User

8. East India In-Vitro Diagnostics (IVD) Market

  • 8.1. Market Size & Forecast, 2019-2030
    • 8.1.1. By Value (USD Billion)
  • 8.2. Market Share & Forecast
    • 8.2.1. By Product and Services
    • 8.2.2. By Technique
    • 8.2.3. By Application
    • 8.2.4. By End User

9. West India In-Vitro Diagnostics (IVD) Market

  • 9.1. Market Size & Forecast, 2019-2030
    • 9.1.1. By Value (USD Billion)
  • 9.2. Market Share & Forecast
    • 9.2.1. By Product and Services
    • 9.2.2. By Technique
    • 9.2.3. By Application
    • 9.2.4. By End User

10. Competitive Landscape

  • 10.1. List of Key Players and Their Offerings
  • 10.2. India In-Vitro Diagnostics (IVD) Company Market Share Analysis, 2023
  • 10.3. Competitive Benchmarking, By Operating Parameters
  • 10.4. Key Strategic Developments (Mergers, Acquisitions, Partnerships, etc.)

11. Impact of Escalating Geopolitical Tensions on India In-Vitro Diagnostics (IVD) Market

12. Company Profiles (Company Overview, Financial Matrix, Competitive Landscape, Key Personnel, Key Competitors, Contact Address, Strategic Outlook, and SWOT Analysis)

  • 12.1. Roche Diagnostic
  • 12.2. Abbott Laboratories
  • 12.3. Beckman Coulter
  • 12.4. Becton and Dickinson
  • 12.5. Sysmex
  • 12.6. Transasia Bio-Medicals Ltd
  • 12.7. Thermo Fisher Scientific Inc
  • 12.8. J Mitra & Co Pvt Ltd
  • 12.9. Advatech Healthcare Pvt Ltd
  • 12.10. Tulip Diagnostics Pvt. Ltd.
  • 12.11. Siemens Healthcare Pvt. Ltd.
  • 12.12. Bio-Rad Laboratories India Pvt. Ltd
  • 12.13. Other Prominent Players

13. Key Strategic Recommendations

14. Research Methodology

  • 14.1. Qualitative Research
    • 14.1.1. Primary & Secondary Research
  • 14.2. Quantitative Research
  • 14.3. Market Breakdown & Data Triangulation
    • 14.3.1. Secondary Research
    • 14.3.2. Primary Research
  • 14.4. Breakdown of Primary Research Respondents, By Region
  • 14.5. Assumptions & Limitations

*Financial information of non-listed companies can be provided as per availability.

**The segmentation and the companies are subject to modifications based on in-depth secondary research for the final deliverable.

Product Code: BWC24657

List of Figures

  • Figure 1 India In-Vitro Diagnostics (IVD) Segmentation
  • Figure 2 India In-Vitro Diagnostics (IVD) Market Value Chain Analysis
  • Figure 3 Company Market Share Analysis, 2023
  • Figure 4 India In-Vitro Diagnostics (IVD) Market Size, By Value (USD Billion), 2019-2030
  • Figure 5 India In-Vitro Diagnostics (IVD) Market Share, By Product and Services, By Value, 2019-2030
  • Figure 6 India In-Vitro Diagnostics (IVD) Market Share, By Technique, By Value, 2019-2030
  • Figure 7 India In-Vitro Diagnostics (IVD) Market Share, By Application, By Value, 2019-2030
  • Figure 8 India In-Vitro Diagnostics (IVD) Market Share, By End User, By Value, 2019-2030
  • Figure 9 North India In-Vitro Diagnostics (IVD) Market Size, By Value (USD Billion), 2019-2030
  • Figure 10 North India In-Vitro Diagnostics (IVD) Market Share, By Product and Services , By Value, 2019-2030
  • Figure 11 North India In-Vitro Diagnostics (IVD) Market Share, By Technique, By Value, 2019-2030
  • Figure 12 North India In-Vitro Diagnostics (IVD) Market Share, By Application, By Value, 2019-2030
  • Figure 13 North India In-Vitro Diagnostics (IVD) Market Share, By End User, By Value, 2019-2030
  • Figure 14 South India In-Vitro Diagnostics (IVD) Market Size, By Value (USD Billion), 2019-2030
  • Figure 15 South India In-Vitro Diagnostics (IVD) Market Share, By Product and Services , By Value, 2019-2030
  • Figure 16 South India In-Vitro Diagnostics (IVD) Market Share, By Technique, By Value, 2019-2030
  • Figure 17 South India In-Vitro Diagnostics (IVD) Market Share, By Application, By Value, 2019-2030
  • Figure 18 South India In-Vitro Diagnostics (IVD) Market Share, By End User, By Value, 2019-2030
  • Figure 19 East India In-Vitro Diagnostics (IVD) Market Size, By Value (USD Billion), 2019-2030
  • Figure 20 East India In-Vitro Diagnostics (IVD) Market Share, By Product and Services , By Value, 2019-2030
  • Figure 21 East India In-Vitro Diagnostics (IVD) Market Share, By Technique, By Value, 2019-2030
  • Figure 22 East India In-Vitro Diagnostics (IVD) Market Share, By Application, By Value, 2019-2030
  • Figure 23 East India In-Vitro Diagnostics (IVD) Market Share, By End User, By Value, 2019-2030
  • Figure 24 West India In-Vitro Diagnostics (IVD) Market Size, By Value (USD Billion), 2019-2030
  • Figure 25 West India In-Vitro Diagnostics (IVD) Market Share, By Product and Services , By Value, 2019-2030
  • Figure 26 West India In-Vitro Diagnostics (IVD) Market Share, By Technique, By Value, 2019-2030
  • Figure 27 West India In-Vitro Diagnostics (IVD) Market Share, By Application, By Value, 2019-2030
  • Figure 28 West India In-Vitro Diagnostics (IVD) Market Share, By End User, By Value, 2019-2030

List of Tables

  • Table 1 India In-Vitro Diagnostics (IVD) Market Size, By Value (USD Billion), 2019-2030
  • Table 2 India In-Vitro Diagnostics (IVD) Market Share, By Product and Services, By Value, 2019-2030
  • Table 3 India In-Vitro Diagnostics (IVD) Market Share, By Technique, By Value, 2019-2030
  • Table 4 India In-Vitro Diagnostics (IVD) Market Share, By Application, By Value, 2019-2030
  • Table 5 India In-Vitro Diagnostics (IVD) Market Share, By End User, By Value, 2019-2030
  • Table 6 North India In-Vitro Diagnostics (IVD) Market Size, By Value (USD Billion), 2019-2030
  • Table 7 North India In-Vitro Diagnostics (IVD) Market Share, By Product and Services , By Value, 2019-2030
  • Table 8 North India In-Vitro Diagnostics (IVD) Market Share, By Technique, By Value, 2019-2030
  • Table 9 North India In-Vitro Diagnostics (IVD) Market Share, By Application, By Value, 2019-2030
  • Table 10 North India In-Vitro Diagnostics (IVD) Market Share, By End User, By Value, 2019-2030
  • Table 11 South India In-Vitro Diagnostics (IVD) Market Size, By Value (USD Billion), 2019-2030
  • Table 12 South India In-Vitro Diagnostics (IVD) Market Share, By Product and Services , By Value, 2019-2030
  • Table 13 South India In-Vitro Diagnostics (IVD) Market Share, By Technique, By Value, 2019-2030
  • Table 14 South India In-Vitro Diagnostics (IVD) Market Share, By Application, By Value, 2019-2030
  • Table 15 South India In-Vitro Diagnostics (IVD) Market Share, By End User, By Value, 2019-2030
  • Table 16 East India In-Vitro Diagnostics (IVD) Market Size, By Value (USD Billion), 2019-2030
  • Table 17 East India In-Vitro Diagnostics (IVD) Market Share, By Product and Services , By Value, 2019-2030
  • Table 18 East India In-Vitro Diagnostics (IVD) Market Share, By Technique, By Value, 2019-2030
  • Table 19 East India In-Vitro Diagnostics (IVD) Market Share, By Application, By Value, 2019-2030
  • Table 20 East India In-Vitro Diagnostics (IVD) Market Share, By End User, By Value, 2019-2030
  • Table 21 West India In-Vitro Diagnostics (IVD) Market Size, By Value (USD Billion), 2019-2030
  • Table 22 West India In-Vitro Diagnostics (IVD) Market Share, By Product and Services , By Value, 2019-2030
  • Table 23 West India In-Vitro Diagnostics (IVD) Market Share, By Technique, By Value, 2019-2030
  • Table 24 West India In-Vitro Diagnostics (IVD) Market Share, By Application, By Value, 2019-2030
  • Table 25 West India In-Vitro Diagnostics (IVD) Market Share, By End User, By Value, 2019-2030
  • Table 26 Roche Diagnostic Company Overview
  • Table 27 Roche Diagnostic Financial Overview
  • Table 28 Abbott Laboratories Company Overview
  • Table 29 Abbott Laboratories Financial Overview
  • Table 30 Beckman Coulter Company Overview
  • Table 31 Beckman Coulter Financial Overview
  • Table 32 Becton and Dickinson Company Overview
  • Table 33 Becton and Dickinson Financial Overview
  • Table 34 Sysmex Company Overview
  • Table 35 Sysmex Financial Overview
  • Table 36 Transasia Bio-Medicals Ltd Company Overview
  • Table 37 Transasia Bio-Medicals Ltd Financial Overview
  • Table 38 Thermo Fisher Scientific Inc Company Overview
  • Table 39 Thermo Fisher Scientific Inc Financial Overview
  • Table 40 J Mitra & Co Pvt Ltd Company Overview
  • Table 41 J Mitra & Co Pvt Ltd Financial Overview
  • Table 42 Advatech Healthcare Pvt Ltd Company Overview
  • Table 43 Advatech Healthcare Pvt Ltd Financial Overview
  • Table 44 Tulip Diagnostics Pvt. Ltd. Company Overview
  • Table 45 Tulip Diagnostics Pvt. Ltd. Financial Overview
  • Table 46 Siemens Healthcare Pvt. Ltd. Company Overview
  • Table 47 Siemens Healthcare Pvt. Ltd. Financial Overview
  • Table 48 Bio-Rad Laboratories India Pvt. Ltd Company Overview
  • Table 49 Bio-Rad Laboratories India Pvt. Ltd Financial Overview
  • Table 50 Other Prominent Players Company Overview
  • Table 51 Other Prominent Players Financial Overview
Have a question?
Picture

Jeroen Van Heghe

Manager - EMEA

+32-2-535-7543

Picture

Christine Sirois

Manager - Americas

+1-860-674-8796

Questions? Please give us a call or visit the contact form.
Hi, how can we help?
Contact us!